E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers H > Headlines for Helix BioPharma Corp. > News item
Published on 11/9/2010 in the Prospect News Convertibles Daily, Prospect News High Yield Daily and Prospect News Preferred Stock Daily.

Helix BioPharma files $75 million shelf covering stock, preferreds

By Devika Patel

Knoxville, Tenn., Nov. 9 - Helix BioPharma Corp. filed a $75 million shelf registration in an F-10 filing with the Securities and Exchange Commission.

The registration covers common shares, preferred shares, warrants and units.

The preferreds may be structured as convertibles.

Proceeds will be used for working capital and general corporate purposes.

Helix BioPharma is an Aurora, Ont., biopharmaceutical company developing products for the treatment of cancer and pre-cancerous conditions.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.